**3. Conclusions**

We have explored possible ways of improving pharmacovigilance among healthcare workers, patients and other stakeholders within the public and private healthcare setting in SSA. Social inclusiveness and engagement are pivotal in understanding the current state of pharmacovigilance in the region.
